Cancer News and Research

Latest Cancer News and Research

Oral sex 'ups' the risk of throat cancer

According to scientists in the U.S. a virus contracted through oral sex is the cause of some throat cancers.

14 May 2007

Daily Aspirin reduces colon cancer risk by 74 percent

Researchers in Britain say an aspirin a day taken over a 10 year period can reduce the risk of colon cancer by as much as 74 percent.

14 May 2007

FDA Panel warns anemia drug dangerous for cancer patients

A panel of experts advising the Food and Drug Administration (FDA) in the United States has warned that the popular anemia drug erythropoietin may not be as safe as first thought.

14 May 2007

Swedish 'snus' linked to a doubled risk of pancreatic cancer

People who use Swedish moist snuff (snus) run twice the risk of developing cancer of the pancreas.

11 May 2007

Should women be prescribed statins?

Women in western countries are more likely to die from heart disease than from cancer.

11 May 2007

Researchers identify human genes targeted by a virus believed to cause Kaposi's sarcoma

University of Florida researchers have identified specific human genes targeted by a virus believed to cause Kaposi's sarcoma, a rare form of cancer associated with AIDS and with organ transplants that causes patches of red or purple tissue to grow under people's skin.

11 May 2007

Researchers equip E. coli with a "riboswitch" chemo-navigational system

Using an innovative method to control the movement of Escherichia coli in a chemical environment, Emory University scientists have opened the door to powerful new opportunities in drug delivery, environmental cleanup and synthetic biology.

11 May 2007

Most women 55 years and younger who have heart attacks don't recognize warning signs

Women younger than 55 years represent less than 5 percent of all hospitalized heart disease patients, but because so many heart attacks occur in the United State each year, even this small percentage affects a large number of people.

11 May 2007

Estrogen may influence the risk for prostate cancer

Although women are four times more likely than men to develop osteoporosis, or porous bone, one in 12 men also suffer from the disease, which can lead to debilitating - or even life-threatening - fractures, mainly of the spine, hip and wrist.

11 May 2007

Health care professionals should inform sensitive patients about the risks of exposure to air pollutants

If you have some form of lung or cardiovascular disease, has your doctor told you how to check today's "AQI", and what to do if it's over 100?

11 May 2007

Oncolytic viruses deliver a knockout punch to cancers

New scientific evidence is helping to build a compelling case for oncolytic viruses as a first-line and adjunctive treatment for many cancers.

11 May 2007

Preoperative chemotherapy reduces chemo-related infections

Giving chemotherapy to women with operable breast cancer before they have surgery 'not after' helps physicians pin down the best treatment regimen and can reduce the extent of surgery, according to a new systematic review.

11 May 2007

Protein findings establish better understanding of tumor development

Peter Baumann, Ph.D., Assistant Investigator, and Nancy Bae, Ph.D., Postdoctoral Research Associate in the Baumann Lab, have published a paper offering insight into the way cells protect chromosome ends from misguided repair.

11 May 2007

New treatment for warts

A clinical trial treating the papillomaviruses responsible for genital warts was on target at the halfway mark, according to Australian of the Year 2006 Professor Ian Frazer and trial manager, sexual health specialist Dr David Jardine

10 May 2007

Researchers discover genetic 'shut down' trigger in healthy immune cells

A fundamental genetic mechanism that shuts down an important gene in healthy immune system cells has been discovered that could one day lead to new therapies against infections, leukemia and other cancers.

10 May 2007

Bisphosphonates for osteoporosis treatment in women

A class of drugs called bisphosphonates has become the new mainstay treatment for postmenopausal women diagnosed with osteoporosis in the post-hormone-replacement era.

10 May 2007

New Cordis device granted Humanitarian Exemption to treat intracranial aneurysms

Cordis Neurovascular, Inc. has announced that the U.S. Food and Drug Administration has granted Humanitarian Device Exemption (HDE) approval for the CORDIS ENTERPRISE Vascular Reconstruction Device and Delivery System for use with embolic coils in the treatment of wide-neck intracranial aneurysms.

10 May 2007